Influenza

Showing NaN - NaN of 70

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated

Not yet recruiting
  • Immunization; Infection
  • +2 more
  • Standard Dose Quadrivalent Inactivated Influenza Vaccine
  • High Dose Quadrivalent Inactivated Influenza Vaccine
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jul 11, 2023

Influenza Trial in Worldwide (Baloxavir Marboxil, Placebo)

Recruiting
  • Influenza
  • Baloxavir Marboxil
  • Placebo
  • Birmingham, Alabama
  • +290 more
Jan 20, 2023

Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (High Dose Quadrivalent Inactivated Influenza

Recruiting
  • Immunization; Infection
  • +3 more
  • High Dose Quadrivalent Inactivated Influenza Vaccine
  • Standard Dose Quadrivalent Inactivated Influenza Vaccine
  • Nashville, Tennessee
    Vanderbilt Univeristy Medical Center
May 27, 2022

Influenza Trial in United States (QIV-HD, Licensed TIV-HD1, Investigational TIV-HD2)

Completed
  • Influenza
  • QIV-HD
  • +2 more
  • Anaheim, California
  • +35 more
Mar 24, 2022

Influenza Trial in United States (FluBlok®, Placebo)

Completed
  • Influenza
  • FluBlok®
  • Placebo
  • Beverly Hills, California
  • +23 more
Mar 24, 2022

Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (High Dose Quadrivalent Inactivated Influenza

Not yet recruiting
  • Immunization; Infection
  • +2 more
  • High Dose Quadrivalent Inactivated Influenza Vaccine
  • Standard Dose Quadrivalent Inactivated Influenza Vaccine
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 21, 2022

Avian Influenza, H1N1 Influenza, Influenza Trial in Nashville (AS03, Influenza Virus Vaccine, Monovalent A/H3N2v

Completed
  • Avian Influenza
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center - Vanderbilt Institute for
Jan 25, 2022

Influenza, Human, Virus Diseases Trial in United States (QIVc, Comparator QIV)

Completed
  • Influenza
  • +2 more
  • QIVc
  • Comparator QIV
  • Mobile, Alabama
  • +46 more
Dec 13, 2021

Influenza Trial in Worldwide (Liquid CAIV-T)

Completed
  • Influenza
  • Liquid CAIV-T
  • Hoover, Alabama
  • +160 more
Sep 10, 2021

Asthma in Children, Vaccine Adverse Reaction, Vaccine Reaction Trial in Durham, Cincinnati, Nashville (Live Attenuated Influenza

Completed
  • Asthma in Children
  • +5 more
  • Live Attenuated Influenza Vaccine (LAIV)
  • Inactivated Influenza Vaccine (IIV)
  • Durham, North Carolina
  • +2 more
Feb 25, 2021

Avian Influenza, Influenza, Influenza Immunisation Trial in United States (drug, biological, other)

Completed
  • Avian Influenza
  • +2 more
  • Birmingham, Alabama
  • +3 more
Jul 16, 2020

Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine

Completed
  • Pregnancy
  • Influenza
  • Quadrivalent Intradermal Influenza Vaccine (QIV)
  • San Diego, California
  • +4 more
Feb 11, 2020

Pregnancy, Influenza Trial in United States (Quadrivalent Influenza Vaccine (QIV))

Completed
  • Pregnancy
  • Influenza
  • Quadrivalent Influenza Vaccine (QIV)
  • San Diego, California
  • +4 more
Feb 11, 2020

Influenza Trial in Nashville (ASO3 Adjuvant, Influenza A/H5N1 Vaccine)

Completed
  • Influenza
  • ASO3 Adjuvant
  • Influenza A/H5N1 Vaccine
  • Nashville, Tennessee
    Vanderbilt University - Pediatric - Vanderbilt Vaccine Research
Oct 18, 2019

Inactivated Influenza Vaccine in Healthy Adults

Completed
  • Influenza
  • +6 more
  • Influenza Vaccine Recipients
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 2, 2019

Influenza Trial in Worldwide (Amantadine, Ribavirin, Oseltamivir, Oseltamivir)

Completed
  • Influenza
  • Birmingham, Alabama
  • +90 more
Jan 31, 2019

Influenza Trial in United States (Seasonal Influenza DNA vaccine, TIV)

Completed
  • Influenza
  • Seasonal Influenza DNA vaccine
  • TIV
  • Atlanta, Georgia
  • +4 more
Dec 4, 2018

Influenza Trial in Worldwide (Influenza vaccine GSK2321138A, FluarixTM, Influenza vaccine GSK2604409A)

Completed
  • Influenza
  • Influenza vaccine GSK2321138A
  • +2 more
  • Chandler, Arizona
  • +41 more
Aug 22, 2018

Influenza Trial in Canada, United States (Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, Placebo)

Completed
  • Influenza
  • Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
  • Placebo
  • Huntsville, Alabama
  • +39 more
May 9, 2018

Influenza Trial in Worldwide (Influsplit Tetra™ vaccine produced by investigational process (IP), Influsplit Tetra™ vaccine

Completed
  • Influenza
  • Influsplit Tetra™ vaccine produced by investigational process (IP)
  • Influsplit Tetra™ vaccine produced by licensed process (LP)
  • Wichita, Kansas
  • +52 more
May 31, 2018

Influenza Trial in Worldwide (40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo)

Completed
  • Influenza
  • 40 mg Laninamivir Octanoate
  • +2 more
  • Scottsboro, Alabama
  • +220 more
May 29, 2018

Influenza Trial in United States (CSL Limited Influenza Virus Vaccine (Afluria®), US Licensed Influenza Virus Vaccine

Completed
  • Influenza
  • CSL Limited Influenza Virus Vaccine (Afluria®)
  • US Licensed Influenza Virus Vaccine (Fluzone®)
  • Mountain Home, Arkansas
  • +12 more
Apr 25, 2018

Influenza Trial in Canada, United States (GSK2340274A, GSK2340273A)

Completed
  • Influenza
  • GSK2340274A
  • GSK2340273A
  • Mesa, Arizona
  • +37 more
Mar 19, 2018

Influenza Trial in United States (High-dose quadrivalent influenza virus vaccine, High-dose influenza virus vaccine, High-dose

Completed
  • Influenza
  • High-dose quadrivalent influenza virus vaccine
  • +2 more
  • Milford, Connecticut
  • +8 more
Feb 5, 2018